The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Novel Compound 2-Methyl-2H-pyrazole-3-carboxylic Acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) Prevents 2,3,7,8-TCDD-Induced Toxicity by Antagonizing the Aryl Hydrocarbon Receptor
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fernandez-Salguero, P. M., Hilbert, D. M., Rudikoff, S., Ward, J. M., & Gonzalez, F. J. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0210 · Cited by 836
Shimada, T., & Fujii‐Kuriyama, Y. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03162.x · Cited by 804
Functional role of AhR in the expression of toxic effects by TCDD
Mimura, J., & Fujii-Kuriyama, Y. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00485-3 · Cited by 746
Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology
Mandal, P. K. (2005) · Journal of Comparative Physiology B · doi:10.1007/s00360-005-0483-3 · Cited by 604
Casper, R. F., Quesne, M., Rogers, I. M., Shirota, T., Jolivet, A., Milgrom, E., & Savouret, J.-F. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12541-2 · Cited by 416
Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context.
Zhang, S., Qin, C., & Safe, S. H. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.6322 · Cited by 340
Ciolino, H. P., Daschner, P. J., Wang, T. T. Y., & Yeh, G. C. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00143-9 · Cited by 241
Couture, L. A., Abbott, B. D., & Birnbaum, L. S. (1990) · Teratology · doi:10.1002/tera.1420420606 · Cited by 240
Chen, I., Safe, S., & Bjeldanes, L. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00060-3 · Cited by 222
Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors.
Suetsugi, M., Su, L., Karlsberg, K., Yuan, Y.-C., & Chen, S. (2003) · PubMed · Cited by 196
Cited by
Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells
Boitano, A. E., Wang, J., Romeo, R., Bouchez, L. C., Parker, A. E., Sutton, S. E., Walker, J. R., Flaveny, C. A., Perdew, G. H., Denison, M. S., et al. (2010) · Science · doi:10.1126/science.1191536 · Cited by 1,047
The aryl hydrocarbon receptor: multitasking in the immune system
Stockinger, B., Meglio, P. D., Gialitakis, M., & Duarte, J. H. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120245 · Cited by 909
Aryl hydrocarbon receptor ligands in cancer: friend and foe
Murray, I. A., Patterson, A. D., & Perdew, G. H. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3846 · Cited by 883
Veldhoen, M., Hirota, K., Christensen, J., O'Garra, A., & Stockinger, B. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081438 · Cited by 520
The Aryl Hydrocarbon Receptor in Barrier Organ Physiology, Immunology, and Toxicology
Esser, C., & Rannug, A. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009001 · Cited by 501
Targeting the IDO1/TDO2–KYN–AhR Pathway for Cancer Immunotherapy – Challenges and Opportunities
Cheong, J. E., & Sun, L. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.11.007 · Cited by 487
Activation of the Aryl Hydrocarbon Receptor Dampens the Severity of Inflammatory Skin Conditions
Di Meglio, P., Duarte, J. H., Ahlfors, H., Owens, N. D. L., Li, Y., Villanova, F., Tosi, I., Hirota, K., Nestle, F. O., Mrowietz, U., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.04.019 · Cited by 373
Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy
Ma, Y., Aymeric, L., Locher, C., Mattarollo, S. R., Delahaye, N. F., Pereira, P., Boucontet, L., Apetoh, L., Ghiringhelli, F., Casares, N., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100269 · Cited by 337
CH223191 Is a Ligand-Selective Antagonist of the Ah (Dioxin) Receptor
Zhao, B., DeGroot, D. E., Hayashi, A., He, G., & Denison, M. S. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq217 · Cited by 312
Role of the Aryl Hydrocarbon Receptor in Carcinogenesis and Potential as a Drug Target
Safe, S., Lee, S.-O., & Jin, U.-H. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft128 · Cited by 264
Okey, A. B. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm096 · Cited by 258
Yamada, T., Horimoto, H., Kameyama, T., Hayakawa, S., Yamato, H., Dazai, M., Takada, A., Kida, H., Bott, D., Zhou, A. C., et al. (2016) · Nature Immunology · doi:10.1038/ni.3422 · Cited by 251
Wang, G.-Z., Zhang, L., Zhao, X.-C., Gao, S.-H., Qu, L.-W., Yu, H., Fang, W.-F., Zhou, Y.-C., Liang, F., Zhang, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08887-7 · Cited by 213
Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution
Sukka, S. R., Ampomah, P. B., Darville, L. N. F., Ngai, D., Wang, X., Kuriakose, G., Xiao, Y., Shi, J., Koomen, J. M., McCusker, R. H., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01115-7 · Cited by 82
AHR Ligands: Promiscuity in Binding and Diversity in Response
DeGroot, D., He, G., Fraccalvieri, D., Bonati, L., Pandini, A., & Denison, M. S. (2011) · The AH Receptor in Biology and Toxicology · doi:10.1002/9781118140574.ch4 · Cited by 43
Henry, E. C., & Gasiewicz, T. A. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.02.005 · Cited by 36
Self-citationIn vitro toxicity and in silico docking analysis of two novel selective AH-receptor modulators
Mahiout, S., Tagliabue, S. G., Nasri, A., Omoruyi, I. M., Pettersson, L., Bonati, L., & Pohjanvirta, R. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.06.010 · Cited by 19
Yu, K., Vyavahare, S., Alhamad, D., Bensreti, H., Ruan, L., Tuladhar, A., Dai, C., Shaver, J. C., Tripathi, A., Ding, K., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.192047 · Cited by 12
Metadata
- Authors
- Kim, S.-H., Henry, E. C., Kim, D.-K., Kim, Y.-H., Shin, K. J., Han, M. S., Lee, T. G., Kang, J.-K., Gasiewicz, T. A., Ryu, S. H., & Suh, P.-G.
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 69
- Issue
- 6
- Pages
- 1871-1878
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2151197941
- Cited by
- 286
- References
- 31
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.